Raymond James Financial’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
Raymond James Financial's PCRX Position: Q3 2026 in Review
Raymond James Financial reduced its Pacira BioSciences (PCRX) stake by 54% in Q3 2026, selling an estimated $547K and leaving 18,485 shares worth $463K. The position accounts for ﹤0.01% of the portfolio, ranked #4604.
Raymond James Financial first reported a position in PCRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.15M in Q2 2025. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.
- Raymond James Financial held 18,485 shares of Pacira BioSciences worth $463K as of Q3 2026.
- Raymond James Financial sold 21,597 Pacira BioSciences shares in Q3 2026, an estimated $547K.
- Pacira BioSciences made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #4604 holding.
- Raymond James Financial first reported a position in Pacira BioSciences in Q4 2024 and has held it in 7 quarters since.
- Raymond James Financial's Pacira BioSciences position peaked at $2.15M in Q2 2025.
- 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.